| |
| |
Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history. | | | | (Cappi Thompson/Getty Images) | | | | | | |  What to know Antibiotic resistance is a growing threat, with over 2.8 million untreatable or difficult-to-treat infections in the U.S. each year. New technologies and therapies are emerging to combat this issue, but the pipeline for new antibiotics remains thin. André O. Hudson, a microbiologist and biochemist, highlights the need for innovative therapies, smarter diagnostics and ecosystem-level strategies. Summary is AI-generated, newsroom-reviewed. What are your thoughts on the potential of bacteriophage therapy and other nontraditional therapies in combating antibiotic resistance? | | | | | How was today's newsletter? | | | | | | | | |
Have a question? Ask the Post AI to learn more 
